Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Sep 5;35(31):3575–3581. doi: 10.1200/JCO.2017.73.8245

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 by American Society of Clinical Oncology

PMC Copyright notice

Fig 1. — Description of cohort. HCC, hepatocellular carcinoma; RDS, reduced dose sorafenib; SDS, starting dose sorafenib. (*) Patients who were determined to have miscoding of their HCC ICD9 codes based on manual chart review; (†) Patients who were prescribed sorafenib but either never picked up the prescription or never ingested pills; (^C)Of the 1,809 RDS patients, 134 patients (7%) had at least one missing variable and therefore could not have propensity score calculated. The remaining 1,675 RDS patients were 1:1 matched to 1,675 SDS patients.